← Back to Search

Behavioural Intervention

OMT Protocol for Type 2 Diabetes

N/A
Waitlist Available
Led By Sonia Rivera-Martinez, DO
Research Sponsored by New York Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Prior hemoglobin A1C test result
Clinical diagnosis of Type II diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial will test whether osteopathic manipulative therapy can help improve blood sugar levels for people with type 2 diabetes. Half the participants will receive real therapy, and half will receive a sham therapy.

Eligible Conditions
  • Type 2 Diabetes
  • Osteopathy

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fasting glucose
Secondary outcome measures
A1C

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: OMT ProtocolExperimental Treatment1 Intervention
Subjects assigned to this arm will have selected osteopathic manipulative treatment techniques administered during the treatment sessions
Group II: OMT-Sham ProtocolPlacebo Group1 Intervention
Subjects assigned to this arm will have sham-osteopathic manipulative treatment techniques administered during the treatment sessions

Find a Location

Who is running the clinical trial?

New York Institute of TechnologyLead Sponsor
51 Previous Clinical Trials
1,971 Total Patients Enrolled
American Osteopathic AssociationOTHER
19 Previous Clinical Trials
3,565 Total Patients Enrolled
Sonia Rivera-Martinez, DOPrincipal InvestigatorNew York Institute of Technology

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for individuals to take part in this experiment?

"Evidently, this clinical trial is still open to new participants - the posting was first published on November 15th 2018 and recent updates were made available April 25th 2022."

Answered by AI

Am I eligible to participate in this experiment?

"In order to qualify for this trial, applicants must have diabetes mellitus type 2 and be between the ages of 30 and 90. This clinical research is seeking approximately one hundred participants."

Answered by AI

Does the research embrace individuals of advanced age?

"Individuals aged between 30 and 90 years may join this trial."

Answered by AI

How many individuals have been accepted to this experiment so far?

"Affirmative. Clinicaltrials.gov lists this trial as actively looking for participants, which were first mentioned on November 15th 2018. As of April 25th 2022, the study is still in need of 100 patients from 2 sites."

Answered by AI
Recent research and studies
~16 spots leftby Apr 2025